Purpose
To study the value of adding collagen matrix (CM) to the surgical procedure combined trabeculotomy-trabeculectomy with mitomycin C (CTTM) for the treatment of Primary congenital  glaucoma (PCG).
Patients and methods
Fourty eyes were operated upon. The CM was inserted under the scleral and conjunctival flaps. Follow up was for 6 -12months
Results
At 6 months; all eyes manifested full success. At 1 year; one eye manifested poor success. There were minimal complications in the form of intraoperative hyphema, vitreous loss and postoperative shallow anterior chamber, immunological reaction and thin avascular cystic blebs.
Conclusion
This study is novel in using both MMC and CM implant at the same time for augmentation of CTT procedure with highest success ever reported for PCG. Biodegradable CM markedly increased the short and long term surgical success with marked reduction of complications.